139 related articles for article (PubMed ID: 31663149)
1. Cholinergic urticaria with hypohidrosis successfully treated with omalizumab.
Ihibashi-Kunimi Y; Imafuku S
J Dermatol; 2020 Feb; 47(2):e47-e48. PubMed ID: 31663149
[No Abstract] [Full Text] [Related]
2. Case Report: Omalizumab for Chronic Spontaneous Urticaria in Pregnancy.
Liao SL; Yu M; Zhao ZT; Maurer M
Front Immunol; 2021; 12():652973. PubMed ID: 33796115
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab in Chronic Spontaneous Urticaria: A Brazilian Real-Life Experience.
Ensina LF; Valle SO; Juliani AP; Galeane M; Vieira dos Santos R; Arruda LK; Melo JM; de Souza PK; Serpa FS; de Andrade DM; França AT; Campos RA; Camelo-Nunes I; Solé D
Int Arch Allergy Immunol; 2016; 169(2):121-4. PubMed ID: 27055122
[TBL] [Abstract][Full Text] [Related]
4. A Case of Hypocomplementemic Urticarial Vasculitis Syndrome Successfully Treated With Omalizumab.
Nucera E; Basta F; Buonomo A; Mezzacappa S; Margiotta DP; Antonelli Incalzi R; Schiavino D
J Investig Allergol Clin Immunol; 2017; 27(6):382-384. PubMed ID: 29199964
[No Abstract] [Full Text] [Related]
5. Efficacy of omalizumab 150 mg/month as a maintenance dose in patients with severe chronic spontaneous urticaria showing a prompt and complete response to the drug.
Asero R
Allergy; 2018 Nov; 73(11):2242-2244. PubMed ID: 29989179
[No Abstract] [Full Text] [Related]
6. A case of aquagenic urticaria successfully treated with omalizumab.
Rorie A; Gierer S
J Allergy Clin Immunol Pract; 2016; 4(3):547-8. PubMed ID: 26852068
[No Abstract] [Full Text] [Related]
7. Omalizumab in chronic spontaneous urticaria: A real-life experience of dose and intervals adjustments in Belgium.
de Montjoye L; Herman A; Dumoutier L; Lambert M; Tromme I; Baeck M
Ann Allergy Asthma Immunol; 2018 Nov; 121(5):620-622. PubMed ID: 30392532
[No Abstract] [Full Text] [Related]
8. Effectiveness and safety of omalizumab in chronic spontaneous or inducible urticaria: evaluation of 154 patients.
Ghazanfar MN; Sand C; Thomsen SF
Br J Dermatol; 2016 Aug; 175(2):404-6. PubMed ID: 26972689
[No Abstract] [Full Text] [Related]
9. Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria.
Curto-Barredo L; Spertino J; Figueras-Nart I; Expósito-Serrano V; Guilabert A; Melé-Ninot G; Cubiró X; Bonfill-Ortí M; Garcias-Ladaria J; Villar M; García-Navarro X; Bielsa-Marsol I; Vilavella M; Aparicio G; Baliu-Piqué C; Álvarez A; Lamas-Domenech N; Duran-Jordà X; Serra-Baldrich E; Giménez-Arnau A
Br J Dermatol; 2018 Jul; 179(1):210-212. PubMed ID: 29368377
[No Abstract] [Full Text] [Related]
10. Personalized omalizumab treatment improves clinical benefit in patients with chronic spontaneous urticaria.
Niemeyer-van der Kolk T; van Maaren MS; van Doorn MBA
J Allergy Clin Immunol; 2018 Dec; 142(6):1992-1994. PubMed ID: 30144475
[No Abstract] [Full Text] [Related]
11. Itch in Urticaria Management.
Deza G; Giménez-Arnau AM
Curr Probl Dermatol; 2016; 50():77-85. PubMed ID: 27578075
[TBL] [Abstract][Full Text] [Related]
12. The maddening itch: an approach to chronic urticaria.
Viegas LP; Ferreira MB; Kaplan AP
J Investig Allergol Clin Immunol; 2014; 24(1):1-5. PubMed ID: 24765875
[TBL] [Abstract][Full Text] [Related]
13. The effect of omalizumab dosing and frequency in chronic idiopathic urticaria: Retrospective chart review.
Clark JJ; Secrest AM; Hull CM; Eliason MJ; Leiferman KM; Gleich GJ; Powell DL
J Am Acad Dermatol; 2016 Jun; 74(6):1274-6. PubMed ID: 27185439
[No Abstract] [Full Text] [Related]
14. What are the effects of omalizumab in refractory chronic spontaneous urticaria?
López M; Navajas-Galimany L
Medwave; 2015 Dec; 15 Suppl 3():e6346. PubMed ID: 26731420
[TBL] [Abstract][Full Text] [Related]
15. Failure of omalizumab in the treatment of solar urticaria.
Müller S; Schempp CM; Jakob T
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):524-5. PubMed ID: 25546321
[No Abstract] [Full Text] [Related]
16. Efficacy and Safety of Omalizumab for Chronic Spontaneous Urticaria: A Systematic Review and Meta-Analysis of Randomized Controlled Trials.
Jia HX; He YL
Am J Ther; 2020; 27(5):e455-e467. PubMed ID: 32427616
[TBL] [Abstract][Full Text] [Related]
17. Update on Omalizumab for Urticaria: What's New in the Literature from Mechanisms to Clinic.
Larenas-Linnemann DES; Parisi CAS; Ritchie C; Cardona-Villa R; Cherrez-Ojeda I; Cherrez A; Ensina LF; Garcia E; Medina IV; Rodríguez-González M; Caraballo JMS
Curr Allergy Asthma Rep; 2018 May; 18(5):33. PubMed ID: 29744661
[TBL] [Abstract][Full Text] [Related]
18. Omalizumab for the Treatment of Chronic Idiopathic Urticaria: Systematic Review of the Literature.
Tonacci A; Billeci L; Pioggia G; Navarra M; Gangemi S
Pharmacotherapy; 2017 Apr; 37(4):464-480. PubMed ID: 28226418
[TBL] [Abstract][Full Text] [Related]
19. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.
Bérard F; Ferrier Le Bouedec MC; Bouillet L; Reguiai Z; Barbaud A; Cambazard F; Milpied B; Pelvet B; Kasujee I; Gharbi H; Lacour JP
Br J Dermatol; 2019 Jan; 180(1):56-66. PubMed ID: 29927483
[TBL] [Abstract][Full Text] [Related]
20. "Chronic Urticaria": Recommendations From an Allergist and Immunologist.
Awosika O; Qureshi A; Ehrlich A; Fonacier L
Dermatitis; 2018; 29(5):292-293. PubMed ID: 30179970
[No Abstract] [Full Text] [Related]
[Next] [New Search]
